Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S (October 1998)
However, as competition in the GLP-1 RAs market becomes more intense, relying solely on effectiveness is no longer enough for products to stand out
Exploring these rare causes requires comprehensive diagnostic evaluations, often involving imaging studies, neurological assessments, and a review of the patients medication regimen
As we continue to ascend, it is imperative to remain guided by evidence-based practices, ethical considerations, and a commitment to improving the quality of life across the lifespan
it means the blend has a wider research-category scope and more variables to interpret
Noise Health 19, 140148